A call for direct sequencing of full-length RNAs to identify all modification

Up Next: The 2023-2024 RNA Innovative Seminar Series has concluded. Seminars will resume in September 2024, check back for updates! 2023 Monday, September 11, 4:00 pm, Graham Erwin, Stanford University Monday, September 25, 4:00 pm, Jeffrey Barrick, UT at AustinMonday, October 9, 4:00 pm, Guizhi (Julian) Zhu, University of MichiganMonday, October 23, 4:00 pm, Susan Gottesman,…
Michael McMillan Ph.D. candidate Cellular and Molecular Biology Mentor: Dr. Sami Barmada Who/what brought you to science? I became interested in science during jr. high and high school after having three great teachers that promoted experimentation and thinking critically about science. I really enjoyed learning the intricacies of nature so I went on to study…
BY PAUL AVEDISIAN The Single Molecule Analysis in Real-Time (SMART) Center, one of two shared-use core facilities of the Center for RNA Biomedicine at the University of Michigan, has been awarded a $1.6 million instrument grant from the National Institutes of Health for a LUMICKS C-TrapⓇ optical tweezers machine with super-resolution fluorescence microscopy, marking a…
By Morgan Sherburne, Michigan News Bacteria need to constantly adapt to compete against other species for nutrient sources and to survive against threats such as antibiotics and toxins. In an effort to understand how bacteria control and regulate this adaptation, University of Michigan researchers from the Center for RNA Biomedicine are examining how RNA polymerase—the…
The latest issue of RNA Translated, the University of Michigan Center for RNA Biomedicine annual magazine and brief report, has been published and is available in print and to view online now! The 2024 issue focuses on our groundbreaking efforts to build a University of Michigan “M-RNA Therapeutics” initiative, led by Michelle Hastings, Ph.D.,…
By Elisabeth Paymal Altogether, over 6,800 rare diseases affect an estimated 25 million to 30 million Americans. These patients who suffer from genetic mutations that often occur within the same family, are still nowadays left with few, if any, therapeutic options. However, RNA on-going discoveries and the development of new technology and tools such as…